Oral OTC Switches Subject To Mandatory CR Packaging Under Proposed Rule
This article was originally published in The Tan Sheet
Executive Summary
A proposed rule requiring all oral Rx-to-OTC switch drugs be packaged in child-resistant containers is being considered by the Consumer Product Safety Commission.
You may also be interested in...
New Use/New Dose OTCs Subject To CR Packaging Under CPSC Rule
Child-resistant packaging would be required for new dosages and new forms of Rx-to-OTC switch drugs, regardless of previous Rx status, under new regulations proposed by the Consumer Product Safety Commission.
New Use/New Dose OTCs Subject To CR Packaging Under CPSC Rule
Child-resistant packaging would be required for new dosages and new forms of Rx-to-OTC switch drugs, regardless of previous Rx status, under new regulations proposed by the Consumer Product Safety Commission.
New Use/New Dose OTCs Subject To CR Packaging Under CPSC Rule
Child-resistant packaging would be required for new dosages and new forms of Rx-to-OTC switch drugs, regardless of previous Rx status, under new regulations proposed by the Consumer Product Safety Commission.